LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 1 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,488 | -53.8% | 20,740 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $65,953 | +34.7% | 20,740 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $48,946 | -32.0% | 20,740 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $71,968 | -52.7% | 20,740 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $152,000 | -85.1% | 20,740 | -89.7% | 0.00% | -88.2% |
| Q1 2022 | $1,019,000 | -34.8% | 201,793 | 0.0% | 0.02% | -22.7% |
| Q4 2021 | $1,562,000 | -48.7% | 201,793 | -2.0% | 0.02% | -56.0% |
| Q3 2021 | $3,047,000 | -62.4% | 205,870 | -58.8% | 0.05% | -66.9% |
| Q2 2021 | $8,113,000 | – | 499,559 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,329,235 | $330,147,000 | 32.44% |
| Apoletto Ltd | 15,167,757 | $246,324,000 | 32.33% |
| Foresite Capital Management IV, LLC | 13,282,181 | $215,703,000 | 29.16% |
| Kirkoswald Asset Management LLC | 1,000 | $16,000 | 9.88% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,320,000 | $21,436,800,000 | 3.90% |
| HSG Holding Ltd | 2,436,798 | $39,574,000 | 2.76% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $26,761,000 | 2.50% |
| Alphabet Inc. | 5,865,125 | $95,250,000 | 1.94% |
| Arena Capital Advisors, LLC- CA | 545,137 | $8,853,000 | 0.73% |
| SB Management Ltd | 3,500,000 | $56,840,000 | 0.67% |